Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

Clinical trial NCT03917082 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03917082
Sponsor: British Columbia Cancer Agency
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Female Hormone Receptor Positive Tumor

Start date: 2019-09-23
Primary completion: 2026-05-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.